CRP and cancer: Like I-CRP other agents also induce activation of caspases but kill cancer cells through a caspase-independent mechanism, such it is the case of bisanthracycline WP 631 [48], selenosemicarbazone metal complexes [49], phenoxazine derivatives [50], among others.